Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Grant or award Director acquired 701 shares (grant or award)
  2. 4 Shares withheld for taxes See Remarks gave up 334 shares (to pay taxes)
  3. 4 Shares withheld for taxes Senior VP, R&D gave up 534 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Operating Officer gave up 444 shares (to pay taxes)
  5. 4 Gift Chief Executive Officer gave 2,000 shares (gift)
  6. 4 Grant or award Director acquired 92 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Senior VP, R&D sold 3,517 shares at $193.73 ($681,348)
  9. 4 Planned sale Chief Executive Officer sold 16,707 shares at an average $197.44 ($3,298,632)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 2,867 shares (to pay taxes)
  11. 4 Shares withheld for taxes Senior VP, R&D gave up 386 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Operating Officer gave up 1,206 shares (to pay taxes)
  13. 4 Shares withheld for taxes See Remarks gave up 386 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 8,386 shares (to pay taxes)
  15. 4 Shares withheld for taxes See Remarks gave up 131 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Operating Officer gave up 219 shares (to pay taxes)
  17. 4 Shares withheld for taxes Senior VP, R&D gave up 135 shares (to pay taxes)
  18. 4 Grant or award Chief Operating Officer acquired 50 shares (grant or award)
  19. 4 Shares withheld for taxes Senior VP, R&D gave up 453 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 3,322 shares (to pay taxes)

Page 6 of 34 · 669 filings